相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Amplification of tumor antigen presentation by NLGplatin to improve chemoimmunotherapy
Yong Zhu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Synergistic Platinum(II) Prodrug Nanoparticles for Enhanced Breast Cancer Therapy
Chen-Xi Yang et al.
MOLECULAR PHARMACEUTICS (2020)
Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator
Yu-Jing He et al.
BIOMATERIALS (2020)
Core-Shell Distinct Nanodrug Showing On-Demand Sequential Drug Release To Act on Multiple Cell Types for Synergistic Anticancer Therapy
Jinsheng Huang et al.
ACS NANO (2019)
New NSAID-Pt(IV) prodrugs to suppress metastasis and invasion of tumor cells and enhance anti-tumor effect in vitro and in vivo
Xue-Qing Song et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Self-Assembled Responsive Bilayered Vesicles with Adjustable Oxidative Stress for Enhanced Cancer Imaging and Therapy
Jibin Song et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer
Gang Chen et al.
ACS NANO (2018)
Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model
Brittany A. Simone et al.
CELL CYCLE (2018)
A new strategy for hydrophobic drug delivery using a hydrophilic polymer equipped with stacking units
Peng-Fei Cui et al.
CHEMICAL COMMUNICATIONS (2018)
A Carrier-Free Nanostructure Based on Platinum(IV) Prodrug Enhances Cellular Uptake and Cytotoxicity
Jingjie Tan et al.
MOLECULAR PHARMACEUTICS (2018)
Regulating the Golgi apparatus by co-delivery of a COX-2 inhibitor and Brefeldin A for suppression of tumor metastasis
Ru-Yi Yu et al.
BIOMATERIALS SCIENCE (2018)
Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors
Myrna Hurtado et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects
Francesco Paolo Intini et al.
INORGANIC CHEMISTRY (2017)
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
Peter M. Bruno et al.
NATURE MEDICINE (2017)
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Timothy C. Johnstone et al.
CHEMICAL REVIEWS (2016)
Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
Wilma Neumann et al.
CHEMMEDCHEM (2015)
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
Antonina V. Kurtova et al.
NATURE (2015)
The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
Rakesh K. Pathak et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
The impact of anti-inflammatory agents on the outcome of patients with colorectal cancer
J. H. Park et al.
CANCER TREATMENT REVIEWS (2014)
Picazoplatin, an Azide-Containing Platinum(II) Derivative for Target Analysis by Click Chemistry
Jonathan D. White et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity
Ghada M. Suddek et al.
CHEMOTHERAPY (2011)
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
H. Cabral et al.
NATURE NANOTECHNOLOGY (2011)
Polymer-Caged Nanobins for Synergistic Cisplatin-Doxorubicin Combination Chemotherapy
Sang-Min Lee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
Alexander Greenhough et al.
CARCINOGENESIS (2009)
Inhibition of transcription by platinum antitumor compounds
Ryan C. Todd et al.
METALLOMICS (2009)
Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation
S. Cafaggi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin
Andrea Kinner et al.
NUCLEIC ACIDS RESEARCH (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells
Ioannis Stasinopoulos et al.
MOLECULAR CANCER RESEARCH (2007)
Inflammation and breast cancer - Cyclooxygenase/prostaglandin signaling and breast cancer
Louise R. Howe
BREAST CANCER RESEARCH (2007)
Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression
SH Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Vasoactive factors and diabetic retinopathy: Vascular endothehal growth factor, cycoloxygenase-2 and nitric oxide
JL Wilkinson-Berka
CURRENT PHARMACEUTICAL DESIGN (2004)
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
S Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice
CH Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
